Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice

References

• Lampeter E. F., Gurniak M., Brocker U., . Regeneration of Beta-cells in Response to Islet Inflammation. Exp. Clin. Endocrinol.. 1995; 103: 74–78Sul2.
   Google Scholar
• Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol.. 1997; 159:4772–4780.
   PubMed Web of Science ®Google Scholar
• Thyssen S., Arany E., Hill D. J.. Ontogeny of regeneration of β-Cells in the neonatal rat after treatment with streptozotocin. Endocrinology. 2006; 147:2346–2356.
   PubMedGoogle Scholar
• Nir T., Melton D. A., Dor Y.. Recovery from diabetes in mice by β-cell regeneration. J. Clin. Invest.. 2007; 117:2553–2561.
   PubMed Web of Science ®Google Scholar
• Piccirillo C. A., d'Hennezel E., Sgouroudis E., Yurchenko E.. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas. Curr. Opin. Immunol.. 2008; 20:655–662.
   PubMed Web of Science ®Google Scholar
• Bach J. F., Chatenoud L.. Tolerance to islet autoantigens in type 1 diabetes. Ann. Rev. Immunol.. 2001; 19:131–161.
   PubMed Web of Science ®Google Scholar
• Delovitch T. L., Singh B.. The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD. Immunity. 1997; 7:727–738.
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A., Rudensky A. Y.. Foxp3 programs the development and function of CD4+CD25+regulatory T cells. Nat. Immunol.. 2003; 4:330–336.
   PubMed Web of Science ®Google Scholar
• Fernandes A., King L. C., Guz Y., . Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology. 1997; 138:1750–1762.
   PubMed Web of Science ®Google Scholar
• Kahan B. W., Jacobson L. M., Hullett D. A., . Pancreatic Precursors and differentiated islet cell types from murine embryonic stem cells. Diabetes. 2003; 52:2016–2024.
   PubMed Web of Science ®Google Scholar
• Jensen J., Heller R. S., Funder-Nielsen T., . Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes. 2000; 49:163–176.
   PubMed Web of Science ®Google Scholar
• Jörns A., Tiedge M., Sickel E. S. L.. Loss of GLUT2 glucose transporter expression in pancreatic beta cells from diabetic Chinese hamsters. Inter. J. Pathol.. 1996; 428:177–185.
   Google Scholar
• Navarro-Tableros V., Fiordelisio T., Hernandez-Cruz A., Hiriart M. A.. Physiological development of insulin secretion, calcium channels, and GLUT2 expression of pancreatic rat β-Cells. Amer. J. Physiol. Endocrinol. Metabol.. 2007; 292:E1018–E1029.
   PubMedGoogle Scholar
• Ablamunits V., Sherry N. A., Kushner J. A., Herold K. C.. Autoimmunity and β-Cell Regeneration in Mouse and Human Type 1 Diabetes. Ann. NY Acad. Sci.. 2007; 1103:19–32.
   PubMed Web of Science ®Google Scholar
• Rosenberg L., Vinik Al. Induction of endocrine cell differentiation: a new approach to management of diabetes. J. Lab. Clin. Med.. 1989; 114:75–83.
   PubMedGoogle Scholar
• Thorel F., Napote V., Avril I., . Conversion of adult pancreatic α-cells to β-cells after extreme β-cell loss. Nature. 2010; 464:1149–1154.
   PubMed Web of Science ®Google Scholar
• Dor Y., Brown J., Martinez O. I., Melton D. A.. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429:41–46.
   PubMed Web of Science ®Google Scholar
• Guz Y., Nasir I., Teitelman G.. Regeneration of pancreatic β-Cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology. 2001; 142:4956–4968.
   PubMed Web of Science ®Google Scholar
• Petropavlovskaia M., Rosenberg L.. Identification and characterization of small cells in the adult pancreas: potential progenitor cells?. Cell Tissue Res.. 2002; 310:51–58.
   PubMedGoogle Scholar
• Chung C. -H., Hao E., Piran R., Keinan E., Levine F.. Pancreatic β-cell neogenesis by direct conversion from mature α-cells. Stem Cells. 2010; 28:1630–1638.
   PubMed Web of Science ®Google Scholar
• Zaret K. S., White M. F.. Diabetes forum: Extreme makeover of pancreatic α-cells. Nature. 2010; 464:1132–1133.
   PubMed Web of Science ®Google Scholar
• Herrera P. -L., Orci L., Vassalli J. -D.. Two transgenic approaches to define the cell lineages in endocrine pancreas development. Mol. Cell. Endocrinol.. 1998; 140:45–50.
   PubMedGoogle Scholar
• Bertelli E., Bendayan M. S.. Intermediate endocrine-acinar pancreatic cells in duct ligation conditions. Amer. J. Physiol. — Cell Physiol.. 1997; 273:C1641–C1649.
   PubMedGoogle Scholar
• Trucco M.. Regeneration of the pancreatic β-cell. J. Clin. Invest.. 2005; 115:5–12.
   PubMed Web of Science ®Google Scholar
• Tuch B. E., Simpson A. M., Campbell I. L.. Role of tumor necrosis factor-alpha and interferon-gamma as growth factors to the human fetal β-cell. J. Clin. Endocrinol. Metabol.. 1991; 73:1044–1050.
   PubMedGoogle Scholar
• Donath M. Y., Størling J., Maedler K., Mandrup-Poulsen T.. Inflammatory mediators and islet ß-cell failure: a link between type 1 and type 2 diabetes. J. Mol. Med.. 2003; 81:455–470.
   PubMed Web of Science ®Google Scholar
• Luo X., Yang H., Kim I. S., . Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic non-obese diabetic mice. Transplantation. 2005; 79:1091–1096.
   PubMed Web of Science ®Google Scholar
• Sherry N. A., Kushner J. A., Glandt M., . Effects of autoimmunity and immune therapy on β-cell turnover in Type 1 diabetes. Diabetes. 2006; 55:3238–3245.
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Rasmussen J. P., Williams L. M., . Regulatory T cell lineage specification by the Forkhead transcription factor Foxp3. Immunity. 2005; 22:329–341.
   PubMed Web of Science ®Google Scholar
• Thornton A. M., Shevach E. M.. CD4+CD25+ immunoregulatory T Cells suppress polyclonal T cell activation in vitro by inhibiting Interleukin 2 production. J. Exper. Med.. 1998; 188:287–296.
   PubMed Web of Science ®Google Scholar
• Judkowski V., Pinilla C., Schroder K., . Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol.. 2001; 166:908–917.
   PubMed Web of Science ®Google Scholar
• Szot G, Koudria P, Bluestone J. Murine pancreatic islet isolation. J. Vis. Exp.. 2007; 7:255.
   Google Scholar
• Waguri M, Yamamoto K, Miyagawa J. I, . Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan. Diabetes. 1997; 46:1281–1290.
   PubMed Web of Science ®Google Scholar
• Akirav E., Kushner J. A., Herold K. C.. Î2-cell mass and Type 1 diabetes. Diabetes. 2008; 57:2883–2888.
   PubMedGoogle Scholar
• Campbell I., Cutri A., Wilson A., Harrison L.. Evidence for IL-6 production by and effects on the pancreatic beta-cell. J. Immunol.. 1989; 143:1188–1191.
   PubMed Web of Science ®Google Scholar